Cadrenal Therapeutics, Inc. Common Stock
Cadrenal Therapeutics, Inc. Common Stock (CVKD) Number of Employees – History & Annual Headcount
Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.
SEC EDGAR · FMP · CVKD · as of Mar 31, 2026
Latest filing snapshot
Cadrenal Therapeutics, Inc. Common Stock (CVKD) employee data is sourced from the annual SEC 10-K filing. As of 2025, full-time employees only. Global consolidated headcount. View SEC filing ↗
CVKD Employee Count
2022 – 2025 · Annual · SEC filingSource: SEC annual filings · Hover bar to view year data · Click to view original filing
Employees History
| Filing Date | Employees | Change (1Y) | Growth (1Y) | SEC filing link |
|---|---|---|---|---|
| 2026-03-31 | 5 | +1 | +25.00% | |
| 2025-03-13 | 4 | +0 | +0.00% | |
| 2024-03-11 | 4 | +1 | +33.33% | |
| 2023-03-30 | 3 | — | — |
▸ Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.
Related Companies — Employee Count
Biotechnology
About CVKD employees
CVKD Employees · Headcount
Cadrenal Therapeutics, Inc. Common Stock (CVKD) employee data is sourced from the annual SEC 10-K filing. As of 2025, Cadrenal Therapeutics, Inc. Common Stock had 5 full-time employees globally. Full-time employees only. Global consolidated headcount.
Cadrenal Therapeutics, Inc. Common Stock's workforce increased by 1 (25.00%) in 2025 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.
Frequently Asked Questions
CVKD Employees · 5 questionsAs of the latest SEC 10-K filing (2025), Cadrenal Therapeutics, Inc. Common Stock had 5 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.
▸ Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2026-03-31